Short intervention program for individuals who attempted suicide in Sweden
Official title: A Randomized Clinical Study of "Attempted Suicide Short Intervention Program" in Swedish Healthcare - ASSIP
Run by Region Skane · NCT04746261 · Data updated 2026-11-12
This study is testing a new short program for people in Sweden who have recently tried to take their own life to see if it can help prevent future attempts when combined with regular treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 460 (estimated) |
| Sponsor | Region Skane Academic / other |
| Locations | 2 sites (Lund and 1 other locations) |
| Status | Recruiting |
| Started | October 15, 2020 |
| Main results expected | June 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | August 20, 2025 |
| Trial ID | NCT04746261 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have recently attempted suicide and are receiving psychiatric care.
✕Probably not a fit
Patients with psychotic illnesses, severe personality disorders, or those unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the Attempted Suicide Short Intervention Program (ASSIP) as a treatment for individuals who have recently attempted suicide. Conducted across six psychiatric clinics in Sweden, the study will recruit 460 patients who will be randomized to receive ASSIP alongside standard treatment or standard treatment alone. The trial aims to assess the effectiveness of ASSIP in preventing future suicide attempts and to identify factors that may influence its success. Additionally, the study will explore the economic benefits of implementing ASSIP in healthcare settings.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the risk of future suicide attempts among patients.
How similar studies have gone: Previous studies, including a randomized controlled trial in Switzerland, have shown promising results for ASSIP, indicating its potential effectiveness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * Signed informed consent to participate in the study. * Contact with psychiatric health care after a suicide attempt within 3 months before the baseline visit * Booked meeting or visit in psychiatry or primary care after visit 1 Exclusion Criteria: * Psychotic illness with current delusions, hallucinations or other negative symptoms that may affect the therapy. * Known emotionally unstable personality disorder (ICD 10) noted in the medical record * Inability to undergo therapy without an interpreter * Mental retardation, dementia, or other circumstances that make it difficult to understand the meaning of participating in the study and giving informed consent.
Where it's running
-
Region Skåne, psykiatri & habilitering, psykiatriforskning skane, Vuxenpsykiatri Lud
Lund, Sweden Recruiting -
Region Skåne, psykiatri & habilitering, psykiatriforskning skane,Vuxenpsykiatri Malmoe
Malmö, Sweden Not yet recruiting
Study contacts
- Principal investigator: Åsa Westrin, professor — Region Skane
- Study coordinator: Åsa Westrin, MD, PhD
- Email: asa.westrin@med.lu.se
- Phone: +4670 624 38 87
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SAFETY family-based program for youths after a suicide attempt
This project will test whether the SAFETY family-based therapy helps 10-17-year-olds who recently attempted suicide avoid repeat attempts.
-
Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression
This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.
-
Mindfulness-based programs for suicidal thoughts and self-harm in Korean youth
We will test whether two mindfulness-based programs for Korean adolescents and young adults reduce suicidal thoughts, self-harm, depression, and problems with sleep and emotion regulation.
-
Youth suicide risk factors and personalized reduction strategies in young adults
This study tests whether combining clinical data, genetic information, neuroimaging, and microbiome data can help identify risk factors and see if a dTMS-based intervention reduces suicide risk in young adults with mood disorders.
-
Long-term follow-up of depression in psychiatric care
This project will follow 415 people with difficult-to-treat depression who were previously studied to see how their symptoms and treatment outcomes change over five years.
-
Improving coping to reduce suicide risk after ED discharge
This study tests whether an electronic safety plan and supportive text messages can help adults who have recently had suicidal thoughts or behaviors after leaving the emergency department.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.